Stock discovery engine
Names are only placed where they earn the label. A company can appear in more than one sleeve — or in none.
High growth with high ROCE, cash conversion and a durable moat.
Indigenous defence-electronics IP with a long order runway and scarce listed peers.
Market-structure compounder on India's financialisation — number two with room to keep taking share.
Software-defined-vehicle specialist — a mid-cap that can still compound if OEM software budgets hold.
Power-grid pick-and-shovel with three engines and still-reasonable economics.
Paediatric hospital compounder with a long new-hospital runway and scarce listed peers.
Profitable adtech compounder on emerging-market digital advertising — not a cash-burn story.
Under-researched generator franchise on data-centre, industrial and export demand.
High-ROCE additives franchise that can keep compounding without leverage or theatre.
Fermentation-API compounder — scarce process, full multiple, clean sheet.
Medical-devices export compounder with rising domestic formalisation on the side.
Premium bakery compounder — real growth, not a hidden 10-bagger from today.
High-margin chemistry pausing — either a re-acceleration setup or a permanently slower compounder.
Materials compounder on abrasives, ceramics and electrominerals — quality over torque.
Diversified machining compounder on auto + industrial capex, with leverage to watch.
Fluorine + CDMO — a quality franchise digesting a heavy investment cycle.
Small or mid cap with accelerating growth, expanding margins and a large TAM.
Indigenous defence-electronics IP with a long order runway and scarce listed peers.
Qualification-moat precision manufacturer on aerospace and energy turbines.
High-complexity EMS plus OSAT optionality on India's manufacturing relocation.
Paediatric hospital compounder with a long new-hospital runway and scarce listed peers.
Transformer supercycle vehicle — high torque, high cycle risk.
Solar manufacturing compounder — policy-backed, execution- and pricing-sensitive.
Profitable adtech compounder on emerging-market digital advertising — not a cash-burn story.
High-growth durables EMS — already re-rated, still riding formalisation.
Hidden water-infra equipment name on India's sewage and industrial water build-out.
Lithium-chem optionality bolted onto a real bromine franchise — finance the option, do not worship it.
Improving fundamentals, still under-owned and under-researched.
Transformer supercycle vehicle — high torque, high cycle risk.
Under-researched generator franchise on data-centre, industrial and export demand.
Hidden water-infra equipment name on India's sewage and industrial water build-out.
Under-owned EMS compounder with export ODM mix and a more reasonable starting multiple.
Fundamentals improving while genuine long-only ownership is rising.
Market-structure compounder on India's financialisation — number two with room to keep taking share.
Software-defined-vehicle specialist — a mid-cap that can still compound if OEM software budgets hold.
Qualification-moat precision manufacturer on aerospace and energy turbines.
Power-grid pick-and-shovel with three engines and still-reasonable economics.
High-complexity EMS plus OSAT optionality on India's manufacturing relocation.
Paediatric hospital compounder with a long new-hospital runway and scarce listed peers.
Solar manufacturing compounder — policy-backed, execution- and pricing-sensitive.
Fermentation-API compounder — scarce process, full multiple, clean sheet.
Medical-devices export compounder with rising domestic formalisation on the side.
High-growth durables EMS — already re-rated, still riding formalisation.
Wind-cycle turnaround — torque is real, history is the risk section, not a footnote.
RAC consolidation plus components backward-integration — a cycle-aware compounder.
Fluorine + CDMO — a quality franchise digesting a heavy investment cycle.
Weak history, but the balance sheet and earnings trajectory are healing.
Wind-cycle turnaround — torque is real, history is the risk section, not a footnote.
Bioenergy engineering — policy floor, adjacency optionality, cycle risk.
High-margin chemistry pausing — either a re-acceleration setup or a permanently slower compounder.
Defence-and-space optics — high narrative, still proving the manufacturing flywheel.
Fluorine + CDMO — a quality franchise digesting a heavy investment cycle.
Custom-synthesis growth that has historically outrun cash — treat every beat with suspicion.
Strong industry, rising share and superior unit economics versus peers.
Indigenous defence-electronics IP with a long order runway and scarce listed peers.
Market-structure compounder on India's financialisation — number two with room to keep taking share.
Software-defined-vehicle specialist — a mid-cap that can still compound if OEM software budgets hold.
Power-grid pick-and-shovel with three engines and still-reasonable economics.
High-complexity EMS plus OSAT optionality on India's manufacturing relocation.
High-ROCE additives franchise that can keep compounding without leverage or theatre.
Materials compounder on abrasives, ceramics and electrominerals — quality over torque.
RAC consolidation plus components backward-integration — a cycle-aware compounder.
Reasonable valuation attached to real growth and improving quality.
Under-researched generator franchise on data-centre, industrial and export demand.
Under-owned EMS compounder with export ODM mix and a more reasonable starting multiple.
Bioenergy engineering — policy floor, adjacency optionality, cycle risk.
Diversified machining compounder on auto + industrial capex, with leverage to watch.